Abstract: The present invention concerns methods for treating a proliferation disorder, such as prostate cancer, basal cell carcinoma, lung cancer, and other cancers, using an inhibitor of the Hedgehog pathway (HhP); and methods for monitoring subjects undergoing such treatments based on biomarkers and other criteria predictive of efficacy.
Type:
Application
Filed:
February 5, 2014
Publication date:
October 23, 2014
Applicant:
HEDGEPATH, LLC.
Inventors:
NICHOLAS J. VIRCA, FRANCIS E. O'DONNELL, JR.